BDBM802114 US20260109672, Reference Example 31

SMILES CC(C)C(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CC1)C(=O)C(=O)C[C@H]1CC1(C)C)C2(C)C)C(C)(C)C

InChI Key InChIKey=MUQLSRDYUXNJLX-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 802114   

TargetReplicase polyprotein 1a(2019-nCoV)
Nxera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 802114BDBM802114(US20260109672, Reference Example 31)
Affinity DataKi:  100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent